Bleeding disorder is a set of disorders, or disease which normally affect the process of clotting of our blood. This bleeding can be in many cases like during an accident, trauma condition, surgery, injury or a menstrual cycle. These bleeding disorders are not only associated with bloods leaving out from our body, rather it can also be an internal bleeding beneath our skin or brain. These may be hemophilia A and B or Willebrand?s disease for example. Sometimes this disease is also termed as royal disease.
The main symptom of bleeding disorder would be excessive bleeding and prolonged clotting time during normal injuries also. These can also easily identified by frequent nose bleeding, heavy menstrual bleeding and unexplained bruishing.
There are mainly two common type of instant treatment available for bleeding disorder, which is iron supplementation or clotting factor repalacement and blood transfusion. These are the therapeutic aspect, but extended research is in progress in various countries, where this disease has a greater prevalence rate.
The mean prevalence of HA (all severities) for our research database was 6.7?0.1 (per 100000 males). Similar results were obtained in Japan (5.9?0.5), Korea (5.3?0.4), and Hong Kong (6.4), all of which were slightly lower than that reported in Singapore (7.8?0.2). Our results demonstrated a lower prevalence that those reported in the Netherlands (11.7), Italy (10.0), United Kingdom (21.4), Canada (14.3), and the United States (10.5). The mean prevalence of HB (all severities) was 1.2?0.1 (per 100000 males). Similar results were also obtained in Japan (1.3?0.1)23 and Singapore (1.1?0.1), which were slightly higher than the results reported for Korea (1.0?0.2), all of which were lower than the results for Italy (2.0), the United Kingdom (4.5),and Canada (3.3).